Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Brain Tumor

  • You have access
    Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
    Ruichao Chai, Guanzhang Li, Yuqing Liu, Kenan Zhang, Zheng Zhao, Fan Wu, Yuzhou Chang, Bo Pang, Jingjun Li, Yangfang Li, Tao Jiang and Yongzhi Wang
    Cancer Biology & Medicine February 2021, 18 (1) 271-282; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0179
  • You have access
    BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas
    Shangfeng Gao, Zhuang Sha, Junbo Zhou, Yihao Wu, Yunnong Song, Cheng Li, Xuejiao Liu, Tong Zhang and Rutong Yu
    Cancer Biology & Medicine February 2021, 18 (1) 88-104; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0096
  • You have access
    HM30181A, a potent P-glycoprotein inhibitor, potentiates the absorption and in vivo antitumor efficacy of paclitaxel in an orthotopic brain tumor model
    Wu Zeng, Betty Yuen Kwan Law, Vincent Kam Wai Wong, Denise So Bik Chan, Simon Wing Fai Mok, Joyce Jia Ying Gao, Rebecca Ka Yan Ho, Xu Liang, Jia Hao Li, Ming Tsung Lee, Weng Li Yoon, Michael P Smolinski, Johnson Yiu Nam Lau, Christopher Wai Kei Lam and Manson Fok
    Cancer Biology & Medicine November 2020, 17 (4) 986-1001; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0128
  • You have access
    Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
    Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu and Tianyi Liu
    Cancer Biology & Medicine August 2020, 17 (3) 555-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0027
  • You have access
    Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway
    Yulong Lan, Jiacheng Lou, Jiliang Hu, Zhikuan Yu, Wen Lyu and Bo Zhang
    Cancer Biology & Medicine February 2020, 17 (1) 112-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0164
  • You have access
    Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis
    Caijun Zha, Xiangqi Meng, Lulu Li, Shan Mi, Da Qian, Ziwei Li, Pengfei Wu, Shaoshan Hu, Shihong Zhao, Jinquan Cai and Yanhong Liu
    Cancer Biology & Medicine February 2020, 17 (1) 154-168; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0353
  • You have access
    Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis
    Yingbin Xie, Yanli Tan, Chao Yang, Xuehao Zhang, Can Xu, Xiaoxia Qiao, Jianglong Xu, Shaohui Tian, Chuan Fang and Chunsheng Kang
    Cancer Biology & Medicine November 2019, 16 (4) 784-796; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0143
  • You have access
    A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses
    Mianfu Cao, Juan Cai, Ye Yuan, Yu Shi, Hong Wu, Qing Liu, Yueliang Yao, Lu Chen, Weiqi Dang, Xiang Zhang, Jingfang Xiao, Kaidi Yang, Zhicheng He, Xiaohong Yao, Yonghong Cui, Xia Zhang and Xiuwu Bian
    Cancer Biology & Medicine August 2019, 16 (3) 595-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0277
  • You have access
    TNFa inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFa signaling
    Li Ma, Chunhua She, Qian Shi, Qiang Yin, Xinxin Ji, Yongrong Wang, Yulong Fan, Xinyao Kong, Peng Li, Zengfeng Sun, Xiaohui Zhang, Zhen Zhang, Jian Wang, Tong Wang, Yuanfu Xu and Wenliang Li
    Cancer Biology & Medicine August 2019, 16 (3) 606-617; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0011
  • You have access
    Circular RNAs and human glioma
    Jinglei Liu, Kun Zhao, Nunu Huang and Nu Zhang
    Cancer Biology & Medicine February 2019, 16 (1) 11-23; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0425
  • Health Services
    • Cardiology
  • Breast Cancer (15)
  • Lung Cancer (18)
  • Gastrointestinal Cancer (13)
  • Cancer Microenvironment (9)
  • Brain Tumor (10)
  • Cancer Epidemiology (7)

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire